• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Ethyl 2,2-difluoropent-4-enoate (CAS No. 110482-96-7): A Compound with Emerging Potential in Chemical and Pharmaceutical Research

Ethyl 2,2-difluoropent-4-enoate, identified by its unique chemical identifier CAS No. 110482-96-7, is a fluorinated ester that has garnered significant attention in the field of organic chemistry and pharmaceutical research. This compound, characterized by its ethyl group and the presence of two fluorine atoms at the alpha position of a pentenoate backbone, exhibits intriguing structural and functional properties that make it a valuable candidate for further exploration.

The molecular structure of Ethyl 2,2-difluoropent-4-enoate consists of a five-carbon chain with double bonds and fluorine substitutions, which contribute to its distinct reactivity and potential applications. The presence of fluorine atoms introduces electron-withdrawing effects, influencing the compound's electronic properties and making it a versatile intermediate in synthetic chemistry. This structural feature has been exploited in various research endeavors to develop novel molecules with enhanced stability and bioactivity.

In recent years, the pharmaceutical industry has shown increasing interest in fluorinated compounds due to their ability to modulate metabolic pathways and improve drug efficacy. Ethyl 2,2-difluoropent-4-enoate has been studied for its potential role in the synthesis of bioactive molecules, including those targeting neurological disorders and inflammatory conditions. The compound's unique chemical profile allows for selective modifications, enabling researchers to tailor its properties for specific therapeutic applications.

One of the most compelling aspects of Ethyl 2,2-difluoropent-4-enoate is its utility as a building block in medicinal chemistry. The combination of its reactive sites—such as the enone double bond and the ester group—provides multiple opportunities for functionalization. This flexibility has been leveraged in the development of novel heterocyclic compounds, which are known for their broad spectrum of biological activities. Researchers have utilized this compound to synthesize derivatives with potential antimicrobial, anti-inflammatory, and even anticancer properties.

The fluorine atoms in Ethyl 2,2-difluoropent-4-enoate also contribute to its stability against degradation processes that might otherwise render similar compounds ineffective. This enhanced stability is particularly important in drug development, where shelf life and bioavailability are critical factors. The compound's resistance to hydrolysis and oxidation makes it a promising candidate for long-term storage and formulation into pharmaceutical products.

Recent studies have highlighted the role of fluorinated esters in enhancing the bioavailability of therapeutic agents. The electronic effects induced by fluorine atoms can improve binding affinity to biological targets, leading to more efficient drug interactions. Ethyl 2,2-difluoropent-4-enoate has been investigated in this context, showing promise as a precursor for drugs that require precise targeting and sustained activity.

The synthesis of Ethyl 2,2-difluoropent-4-enoate involves sophisticated organic reactions that showcase the compound's synthetic utility. Advanced methodologies such as cross-coupling reactions and fluorination techniques have been employed to construct its molecular framework efficiently. These synthetic strategies not only highlight the compound's versatility but also demonstrate the advancements in synthetic organic chemistry that enable the creation of complex fluorinated molecules.

In conclusion, Ethyl 2,2-difluoropent-4-enoate (CAS No. 110482-96-7) represents a significant advancement in chemical research with potential applications across multiple disciplines. Its unique structural features and reactivity make it an invaluable tool for developing novel pharmaceuticals and specialty chemicals. As research continues to uncover new uses for this compound, it is likely to play an increasingly important role in addressing complex scientific challenges.

• 140420-95-7(Hexadecanoic acid, 2,2-difluoro-, ethyl ester)
• 3885-22-1(4-Pentenoic acid, 2-fluoro-, ethyl ester)
• 151309-48-7(Tetradecanoic acid,2,2-difluoro-, ethyl ester)
• 88128-46-5(Butanoic acid, 2,2-difluoro-4-hydroxy-, ethyl ester)
• 88128-45-4(Butanedioic acid, 2,2-difluoro-, 1-ethyl ester)
• 1000339-45-6(Butyl 2,2-difluorobutanoate)
• 428-97-7(Diethyl 2,2-difluoropentanedioate)
• 136854-22-3(Ethyl 2,2-Difluoropentanoate)
• 111934-78-2(4-Pentenoic acid, 2,2-difluoro-, methyl ester)
• 74106-81-3(Ethyl 2,2-difluorohexanoate)